Drawing on real-world experience, we will walk participants through the most common red flags, key evaluation criteria, and what “investment-ready” actually means in practice. The session includes a simulated “due diligence case,” where we dissect pitch decks, commercial pressure points, and include a critical—yet often overlooked—data room drill, highlighting typical pitfalls and winning signals.
Biological products hold enormous promise for the future of agriculture, but early validation remains one of the biggest hurdles for young AgBiotech companies. This session explores how startups can shorten development cycles through smart field-testing strategies, efficient regulatory navigation and early collaboration with receptive growers and scientific partners. Investors share what evidence builds their conviction, […]
Biotechnology is fundamentally transforming the way we grow, protect and improve our food supply. From gene editing to precision fermentation, the pace of scientific advancement in plant sciences is opening new possibilities for a more resilient, productive and sustainable agricultural sector. In this session, Richard Harrison, Managing Director of the Plant Sciences Group at Wageningen […]
